jueves, 16 de abril de 2026

Bicillin® L-A Shortage

https://www.hiv.gov/blog/bicillin-l-a-shortage?utm_source=newsletter&utm_medium=email&utm_campaign=blog&j=2951969&sfmc_sub=6992026&l=6498_HTML&u=73303456&mid=100006181&jb=0 CDC has learned that the U.S. Food and Drug Administration (FDA) is allowing the temporary importation of Lentocilin© due to the ongoing limited availability and extended recovery of Bicillin® L-A (Penicillin G Benzathine Injectable Suspension, produced by King Pharmaceuticals LLC, a subsidiary of Pfizer). The National Network of STD Prevention Training Centers has posted information for health care providers on the administration of Lentocilin©. https://courses.nnptc.org/resource_detail.html?id=2718

No hay comentarios:

Publicar un comentario